Source: International Congress 2019 – CCC Interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Mari (Roma (RM), Italy). Alemtuzumab-induced alveolar hemorrhage in relapsing-remitting Multiple Sclerosis: learning from adversity. International Congress 2019 – CCC Interstitial lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Minimal skin involvement in systemic sclerosis does not preclude pulmonary involvement – an analysis of the German Network for Systemic Sclerosis (DNSS) Registry Source: Eur Respir J 2007; 30: Suppl. 51, 66s Year: 2007 Amyotrophic lateral sclerosis: predictors of respiratory impairment at disease diagnosis Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019 The case of pulmonary fibrosis and amyotrophic lateral sclerosis: is intubation always futile? Source: International Congress 2017 – End-of-life care of the respiratory patients Year: 2017 Amyotrophic lateral sclerosis: a not-so-rare disease Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure Year: 2017 Three cases of idiopathic pleuroparenchymal fibroelastosis associated with amyotrophic lateral sclerosis Source: International Congress 2014 – ILDs 4 Year: 2014 Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Sleep disorders in a cohort of Amyotrophic Lateral Sclerosis patients Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Respiratory function monitoring in amyotrophic lateral sclerosis patients: 1-year analysis Source: Virtual Congress 2021 – New insights into lung function testing Year: 2021 Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Predictive factors of hypoventilation during amyotrophic lateral sclerosis (ALS) Source: Annual Congress 2010 - From the acute to the chronic patient: how do we use noninvasive ventilation? Year: 2010 Amyotrophic lateral sclerosis (ALS): follow-up respiratory failure Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Hemoptysis: rare pulmonary manifestation of tuberous sclerosis in childhood Source: Eur Respir J 2006; 28: Suppl. 50, 544s Year: 2006 Rate of FEV1 decline in lymphangioleiomyomatosis associated with tuberous sclerosis complex Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Interstitial lung disease in systemic sclerosis: where do we stand? Source: Eur Respir Rev 2015; 24: 411-419 Year: 2015 Disease course and outcome of progressive interstitial lung disease in systemic sclerosis Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019 Predicting respiratory failure in amyotrophic lateral sclerosis: recruiting a few good pulmonologists Source: Eur Respir J, 53 (4) 1900360; 10.1183/13993003.00360-2019 Year: 2019 Survival factors of amyotrophic lateral sclerosis patients under pneumology follow-up Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation Year: 2017 Severity and outcome of cystic lung disease in women with tuberous sclerosis complex Source: Eur Respir J 2015; 45: 171-180 Year: 2015 A mismatch between dyspnea and general-respiratory functional tests in patients with Amyotrophic Lateral Sclerosis Source: International Congress 2018 – Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions Year: 2018